These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9480829)

  • 1. Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation.
    Le Page C; Sanceau J; Drapier JC; Wietzerbin J
    Biochem Biophys Res Commun; 1998 Feb; 243(2):451-7. PubMed ID: 9480829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inhibitors of ADP-ribosylation on macrophage activation.
    Le Page C; Pellat-Deceunynck C; Drapier JC; Wietzerbin J
    Adv Exp Med Biol; 1997; 419():203-7. PubMed ID: 9193655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal drug benznidazole impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription through inhibition of NF-kappaB activation.
    Piaggio E; Sancéau J; Revelli S; Bottasso O; Wietzerbin J; Serra E
    J Immunol; 2001 Sep; 167(6):3422-6. PubMed ID: 11544334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
    Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
    J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the mouse inducible-type nitric oxide synthase gene promoter by interferon-gamma, bacterial lipopolysaccharide and NG-monomethyl-L-arginine.
    Weisz A; Cicatiello L; Esumi H
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):209-15. PubMed ID: 8645207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-gamma-treated RAW 264.7 cells.
    Momose I; Terashima M; Nakashima Y; Sakamoto M; Ishino H; Nabika T; Hosokawa Y; Tanigawa Y
    Biochim Biophys Acta; 2000 Oct; 1498(1):19-31. PubMed ID: 11042347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular role of ascorbate in enhancement of NO production in activated macrophage-like cell line, J774.1.
    Mizutani A; Tsukagoshi N
    J Nutr Sci Vitaminol (Tokyo); 1999 Aug; 45(4):423-35. PubMed ID: 10575633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering of peritoneal macrophages with IFN-alpha/beta attenuates the expression of inducible nitric oxide synthase through a decrease in NF-kappaB activation.
    López-Collazo E; Hortelano S; Rojas A; Boscá L
    J Immunol; 1998 Mar; 160(6):2889-95. PubMed ID: 9510192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages.
    Huang KC; Chen CW; Chen JC; Lin WW
    J Biomed Sci; 2003; 10(4):396-405. PubMed ID: 12824699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors and antioxidants modulate NF-kappaB and NOS-II induction in retinal epithelial cells.
    Faure V; Courtois Y; Goureau O
    Am J Physiol; 1998 Jul; 275(1):C208-15. PubMed ID: 9688852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.
    De Stefano D; Maiuri MC; Iovine B; Ialenti A; Bevilacqua MA; Carnuccio R
    J Mol Med (Berl); 2006 Jan; 84(1):65-74. PubMed ID: 16284791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
    Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
    Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B.
    Kleinert H; Euchenhofer C; Ihrig-Biedert I; Förstermann U
    Mol Pharmacol; 1996 Jan; 49(1):15-21. PubMed ID: 8569701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide.
    Morris KR; Lutz RD; Choi HS; Kamitani T; Chmura K; Chan ED
    Infect Immun; 2003 Mar; 71(3):1442-52. PubMed ID: 12595462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages.
    Kang JS; Jeon YJ; Kim HM; Han SH; Yang KH
    J Pharmacol Exp Ther; 2002 Jul; 302(1):138-44. PubMed ID: 12065710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docosahexaenoic acid decreases IRF-1 mRNA and thus inhibits activation of both the IRF-E and NFkappa d response elements of the iNOS promoter.
    Kielar ML; Jeyarajah DR; Penfield JG; Lu CY
    Transplantation; 2000 May; 69(10):2131-7. PubMed ID: 10852612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways.
    Crespo A; Filla MB; Murphy WJ
    Eur J Immunol; 2002 Mar; 32(3):710-9. PubMed ID: 11870615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ergolide, sesquiterpene lactone from Inula britannica, inhibits inducible nitric oxide synthase and cyclo-oxygenase-2 expression in RAW 264.7 macrophages through the inactivation of NF-kappaB.
    Whan Han J; Gon Lee B; Kee Kim Y; Woo Yoon J; Kyoung Jin H; Hong S; Young Lee H; Ro Lee K; Woo Lee H
    Br J Pharmacol; 2001 Jun; 133(4):503-12. PubMed ID: 11399667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.